Clinical trial
The Pharmacokinetic of the Fixed-dose Combination of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnant Women
NCT00701961 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Pharmacokinetic of the Fixed-dose Combination of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnant Women
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- July 31, 2009
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plasmodium falciparum malaria